Body Weight Clinical Trial
— PRAESIIDIUMOfficial title:
Physics Informed Machine Learning-based Prediction and Reversion of Impaired Fasting Glucose Management
In this prospective, non-randomized, monocentric study, data will be collected from otherwise healthy individuals with overweight/obese grade I to increase data availability in the pre-diabetes field (impaired glucose intolerance), and to validate the outputs of an algorithm for the "physics-informed machine learning (PIML)" designed to estimate the real-time risk of prediabetes. Each participant will take part in the study for 4 months, including 3 onsite visits. During the screening visit, participants' eligibility will be determined by checking the inclusion and exclusion criteria after detailed information and obtaining informed consent by the investigator. Blood will be withdrawn for exclusion of existing prediabetes/diabetes at the fasted state. For women in reproductive age, a urinary pregnancy test will be performed. After getting the results of blood tests (glucose and HbA1c), participants will be asked to participate in study. On the visit 1, eligible participants will arrive at the study centre in a fasting state. Blood samples will be collected and participants will get vials and instructions for collection of stool and urine samples. Anthropometric data, lifestyle habit (cigarette, alcohol consumption) and family history will be collected. A 6-minute walking test to determine VO2 max will then be performed. Participants will receive a blinded Abbott Libre Pro glucose sensor, which they will wear for the next 14-days. Further, participants will be provided with a Fitbit Charge 5 health and fitness wristband. For validation purposes some part of study participants will be kindly asked to test newly develop wrist-worn device (EDIBit). With the help of 24-hour food recall, study subjects will be trained by medical staff on how to correctly enter their food intake in the Study app for completion of digital 3-day food diaries. They will be asked to fill in the diaries for 3 days after study visit1 and 3 days before study visit2. They will also receive a food frequency questionnaire during visit1. The second study visit will run nearly identical to study visit1 (except for food frequency questionnaire which will be omitted). During this visit, participants will receive information sheets on physical activity and dietary recommendations. The third and last visit will run nearly identically to the study visit2, except that no new glucose sensor will be inserted and also stool samples will not be collected.
Status | Not yet recruiting |
Enrollment | 75 |
Est. completion date | March 31, 2025 |
Est. primary completion date | March 31, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Healthy adult volunteers (age = 18 years old); - Overweight (BMI 25 - 29.9 kg/m2) and obese grade I individuals (with BMI 30 - 34.9 kg/m2); - Written consent of the participant after being informed; - Ownership of a smartphone running Android or iOS. Exclusion Criteria: - Non-compliance; - Ongoing treatment with immunosuppressive and/or anti-inflammatory medications (NSAIDs, glucocorticoids, chemotherapy, biologicals); - Ongoing treatment with glucose lowering drugs, except if anti-diabetic medication has not been stopped - for metformin one month, for GLP-1 RA, tirzepatide - two months prior enrolment; - Presence of autoimmune and/or inflammatory disease (autoimmune thyroid disease, psoriasis, inflammatory bowel disease); - Skin conditions hindering application of continuous glucose monitoring systems; - Diabetes or prediabetes as diagnosed by ADA/WHO criteria according to fasting glucose and/or HbA1c; - High risk alcohol consumption - according to NIAAA - National Institute on Alcohol Abuse and Alcoholism (for men - more than 4 drinks on any day or more than 14 drinks per week; for women - more than 3 drinks on any day or more than 7 drinks per week); - Factors otherwise limiting the participation in the study according to the judgement of the investigator; - Pregnancy or intention to get pregnant during the study timeline. |
Country | Name | City | State |
---|---|---|---|
Latvia | University of Latvia, Faculty of Medicine | Riga |
Lead Sponsor | Collaborator |
---|---|
Jelizaveta Sokolovska | CheckHealth, Euronet-Consulting, HK3 Lab S.R.L., Italy, Medical University of Graz, Scuola di Robotica, Spindox Labs, The Institute of Electronics and Computer Sciences, Latvia, The Italian Liver Foundation, The National Research Council, Italy |
Latvia,
Al-Shamsi S, Govender RD, King J. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study. BMJ Open. 2020 Oct 28;10(10):e040680. doi: 10.1136/bmjopen-2020-040680. — View Citation
Almeda-Valdes P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol. 2009;8 Suppl 1:S18-24. — View Citation
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33. doi: 10.2337/dc21-S002. Erratum In: Diabetes Care. 2021 Sep;44(9):2182. — View Citation
Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Prim Care Diabetes. 2018 Dec;12(6):517-525. doi: 10.1016/j.pcd.2018.07.015. Epub 2018 Aug 18. — View Citation
Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE, Moons KG. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003 Sep;56(9):826-32. doi: 10.1016/s0895-4356(03)00207-5. — View Citation
Castiglione F, Tieri P, De Graaf A, Franceschi C, Lio P, Van Ommen B, Mazza C, Tuchel A, Bernaschi M, Samson C, Colombo T, Castellani GC, Capri M, Garagnani P, Salvioli S, Nguyen VA, Bobeldijk-Pastorova I, Krishnan S, Cappozzo A, Sacchetti M, Morettini M, Ernst M. The onset of type 2 diabetes: proposal for a multi-scale model. JMIR Res Protoc. 2013 Oct 31;2(2):e44. doi: 10.2196/resprot.2854. — View Citation
Centers for Disease Control and Prevention. National Diabetes Statistics Report 2020 Website. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf
Ellahham S. Artificial Intelligence: The Future for Diabetes Care. Am J Med. 2020 Aug;133(8):895-900. doi: 10.1016/j.amjmed.2020.03.033. Epub 2020 Apr 20. — View Citation
Ezzati M, Riboli E. Can noncommunicable diseases be prevented? Lessons from studies of populations and individuals. Science. 2012 Sep 21;337(6101):1482-7. doi: 10.1126/science.1227001. — View Citation
Hegde H, Shimpi N, Panny A, Glurich I, Christie P, Acharya A. Development of non-invasive diabetes risk prediction models as decision support tools designed for application in the dental clinical environment. Inform Med Unlocked. 2019;17:100254. doi: 10.1016/j.imu.2019.100254. Epub 2019 Oct 16. — View Citation
International Diabetes Federation. IDF Diabetes Atlas, 10th Edn. Brussels, Belgium: 2021. Available at: Https://www.Diabetesatlas.Org.
Jolle A, Midthjell K, Holmen J, Carlsen SM, Tuomilehto J, Bjorngaard JH, Asvold BO. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Res Care. 2019 Nov 28;7(1):e000769. doi: 10.1136/bmjdrc-2019-000769. eCollection 2019. — View Citation
Karniadakis GE, Kevrekidis IG, Lu L, Perdikaris P, Wang S, Yang L. Physics-informed machine learning. Nat Rev Phys. 2021;3(6):422-440. doi:10.1038/s42254-021-00314-5
Ley SH, Schulze MB, Hivert MF, Meigs JB, Hu FB. Risk Factors for Type 2 Diabetes. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 13. Available from http://www.ncbi.nlm.nih.gov/books/NBK567966/ — View Citation
Palumbo MC, de Graaf AA, Morettini M, Tieri P, Krishnan S, Castiglione F. A computational model of the effects of macronutrients absorption and physical exercise on hormonal regulation and metabolic homeostasis. Comput Biol Med. 2023 Sep;163:107158. doi: 10.1016/j.compbiomed.2023.107158. Epub 2023 Jun 16. — View Citation
Palumbo MC, Morettini M, Tieri P, Diele F, Sacchetti M, Castiglione F. Personalizing physical exercise in a computational model of fuel homeostasis. PLoS Comput Biol. 2018 Apr 26;14(4):e1006073. doi: 10.1371/journal.pcbi.1006073. eCollection 2018 Apr. — View Citation
Piovani D, Nikolopoulos GK, Bonovas S. Non-Communicable Diseases: The Invisible Epidemic. J Clin Med. 2022 Oct 8;11(19):5939. doi: 10.3390/jcm11195939. — View Citation
Prana V, Tieri P, Palumbo MC, Mancini E, Castiglione F. Modeling the Effect of High Calorie Diet on the Interplay between Adipose Tissue, Inflammation, and Diabetes. Comput Math Methods Med. 2019 Feb 3;2019:7525834. doi: 10.1155/2019/7525834. eCollection 2019. — View Citation
Riley RD, Ensor J, Snell KI, Debray TP, Altman DG, Moons KG, Collins GS. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ. 2016 Jun 22;353:i3140. doi: 10.1136/bmj.i3140. Erratum In: BMJ. 2019 Jun 25;365:l4379. — View Citation
Rodrigues PM, Madeiro JP, Marques JAL. Enhancing Health and Public Health through Machine Learning: Decision Support for Smarter Choices. Bioengineering (Basel). 2023 Jul 2;10(7):792. doi: 10.3390/bioengineering10070792. — View Citation
Stolfi P, Valentini I, Palumbo MC, Tieri P, Grignolio A, Castiglione F. Potential predictors of type-2 diabetes risk: machine learning, synthetic data and wearable health devices. BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):508. doi: 10.1186/s12859-020-03763-4. — View Citation
Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012 Jun 16;379(9833):2279-90. doi: 10.1016/S0140-6736(12)60283-9. Epub 2012 Jun 9. — View Citation
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1. — View Citation
Yang J, Qian F, Chavarro JE, Ley SH, Tobias DK, Yeung E, Hinkle SN, Bao W, Li M, Liu A, Mills JL, Sun Q, Willett WC, Hu FB, Zhang C. Modifiable risk factors and long term risk of type 2 diabetes among individuals with a history of gestational diabetes mellitus: prospective cohort study. BMJ. 2022 Sep 21;378:e070312. doi: 10.1136/bmj-2022-070312. — View Citation
Yao H, Shum AJ, Cowan M, Lahdesmaki I, Parviz BA. A contact lens with embedded sensor for monitoring tear glucose level. Biosens Bioelectron. 2011 Mar 15;26(7):3290-6. doi: 10.1016/j.bios.2010.12.042. Epub 2010 Dec 31. — View Citation
Zafar H, Channa A, Jeoti V, Stojanovic GM. Comprehensive Review on Wearable Sweat-Glucose Sensors for Continuous Glucose Monitoring. Sensors (Basel). 2022 Jan 14;22(2):638. doi: 10.3390/s22020638. — View Citation
* Note: There are 26 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Validation of the Mission T2D (MT2D) algorithm outputs, that predicts the real time risk for developing pre-diabetes. | Data collections has three main purposes input data for the in-silico MT2D model (gender, weight, height, number of sessions of physical activity, duration of the bout of physical activity, intensity in terms of %VO2max, 3 meals per day (specified macronutrients).
Validation of the MT2D outputs include inflammation markers, metabolic outcomes. The third data for training/validation of the physics-informed machine learning (PIML) algorithm: demographic data; health-related data; lifestyle data (e.g., food consumption data and physical activity data); continuous ingestion through wearable sensors (Continuous Glucose Monitoring (CGM and tracker of physical activity e.g., Fitbit Charge 5, EDIBit.) |
The study will run for 15 months. During this period, 75 individuals will be followed for 4 months, including screening visit and three onsite visits, if participants meet the predetermined inclusion criteria. Time frame between visits are 65 days (± 10 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Not yet recruiting |
NCT06026631 -
Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study.
|
N/A | |
Completed |
NCT03850990 -
Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss
|
N/A | |
Not yet recruiting |
NCT03601273 -
Bariatric Embolization Trial for the Obese Nonsurgical
|
Phase 1 | |
Completed |
NCT02899559 -
Messages and Plans to Increase Gym Utilization
|
N/A | |
Active, not recruiting |
NCT02557022 -
Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight
|
N/A | |
Completed |
NCT02158130 -
Effects of Aerobic Exercise Detraining
|
N/A | |
Completed |
NCT02188251 -
A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants
|
Phase 2 | |
Completed |
NCT02402985 -
Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics
|
N/A | |
Completed |
NCT01665339 -
Preload, Weight Management, Risk of Cardiovascular Disease
|
Phase 3 | |
Completed |
NCT01131871 -
Innovative Approaches to Diet, Exercise and Activity
|
Phase 2 | |
Completed |
NCT01170390 -
Oral Contraceptives and Body Mass Index
|
Phase 4 | |
Completed |
NCT02395835 -
Methylation of the PPARg Promoter Region in Pregnancy
|
N/A | |
Completed |
NCT00814554 -
Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers
|
N/A | |
Completed |
NCT04901949 -
The Course of Acute Pancreatitis in Patients With Different BMI Groups
|
||
Active, not recruiting |
NCT03843424 -
Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers
|
N/A | |
Active, not recruiting |
NCT03575897 -
Serial Assessment of Body Fat Accrual in Very Preterm Infants
|
N/A | |
Active, not recruiting |
NCT05601804 -
TARGETing Healthy Weight Loss in the Context of Food Insecurity
|
||
Not yet recruiting |
NCT05004558 -
Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias
|
N/A |